219 research outputs found
Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure.
No full textBACKGROUND & AIMS: Nucleotide polymorphisms upstream of the interleukin 28B (IL28B) gene are strongly associated with hepatitis C virus (HCV) clearance in treatment-naïve patients treated with peginterferon/ribavirin (PegIFN/RBV). This subanalysis of the REALIZE study evaluated the impact of IL28B polymorphisms on sustained virologic response (SVR) in telaprevir-treated, HCV genotype 1-infected patients with prior PegIFN/RBV treatment failure.
METHODS: Treatment-experienced patients were randomized to 12 weeks of telaprevir (750 mg every 8h) with/without a 4-week PegIFN/RBV lead-in, or placebo, each with PegIFN-α-2a (180 μg/week) and ribavirin (1000-1200 mg/day) for 48 weeks overall. Data from telaprevir arms were pooled.
RESULTS: Eighty percent (527/662) of patients consented to genetic testing and were included. Similar proportions of patients had IL28B CC, CT and TT genotypes across treatment arms; baseline characteristics were generally well balanced. SVR rates were higher in the pooled telaprevir versus placebo group for all IL28B genotypes; CC: 79% versus 29%, respectively; CT: 60% versus 16%, respectively; TT: 61% versus 13%, respectively. Within each prior response category (relapse, partial or null response), SVR and viral breakthrough rates with telaprevir-based treatment were comparable across IL28B genotypes. IL28B genotype did not significantly affect SVR (2-step multivariate analyses; p >0.16 in pairwise comparison among CC, TT, and CT). Variations in rapid virologic response and relapse rates were noted in certain patient subgroups.
CONCLUSIONS: Our findings suggest that IL28B genotype has a limited impact on SVR rates with telaprevir-based therapy in treatment-experienced patients. IL28B genotyping may have limited utility in the baseline evaluation of similar patients considered for telaprevir-based therapy
16
No full textCENTURY EDITION PALO ALTO -LIVE OAK
XeaMng Business flhctx of palo Rlto
ATTORNEYS ami NOTARIES
1'UBI.IC-
8. W. (Iiarles
<■. «i. Wigle -
W. K. Norris
BARBEKS-
•I. U. Lorkin
W. C Wfani
SkuteBros.
IIILLIAKIIS-
Farrain &. Slade
l/mis ttraut
BLACKSMITHS—
Mullen & Harms
(',. E. t lilcri'st
BOOKSELLERS ANDSTATIONEUS
Merguire Bros.
; 11. W. Simkins
BRICK und CEMENT WORK—
Its. Downar
A. McLachlan
BUILDING MATERIALS—
Parkinson Lumber and<
J—'. liiirdwamiii. :__
CVCLER1ES-
Orr & Peterson
F. L. (Vandall
' W. H. llusted
DENTISTS- . •
Dr. a W. Decker
Dr. H. D. Dodge
Dr. 0. B: little
druggists—
B. P. Hall
Edw. 0. Webb Jr.
DRY GOODS—
Mrs. (!. (latrander
Ferguson & Co.
FEED AND FUEL—
F. U Worrell
J. K. Plannelly
Downing & Son
t'URNITURK—
F. W. Sherman & Cx>.
C K. Spaulding
Tacoma Mill Co. ~" — ■-
CANDY MANUFACTURERS—
The Spa, Ernest Wilson
A. N. Umphreys
CONTRACTORS AND BUILDEKS-
11. U rpham
G. I-iumKiAtt-r
J. W.'Wells
G. W. Mosher
E. A. Hettinger
GROCERS—
J. C. Black & Son
G. W. La lMere & Son
Earle & ('.
Jordan's Cash Storj
FuUer & Co.
JEWELERS—
H. D. Botfield
1'. I.. Seaman*
LIVERY STABLES—
R. B. Bell's Stables
. 0. N. Reynolds
MEAT AND PISH MARKETS-
(I. J. Carey
James Blake
I. T. Osburn
MERCHANT TAILORS-
F. C. Thiele
A. It. Allison
NEWSPAPERS—
Palo Alto Live Oak
Palo Alto Times "
PAINTERS—
Stroner & Backus
Callahan MacCarthy
PHYSICIANS—
W. W. Gamble, M. D
W. L. Adams, M. D.
C. G. Gordon, M. D.
Howard Black, M. D.
H. H. Pillsbury, M. D.
"iirP: llllshnry, M. Br—
~—Gr E. Hallv M;- D.; ==
PLUMBERS—
IiOuis Dahl
Geo. B. Lucas"
11 A Gairaud
REAL ESTATE—
■'3.3. Morris
John F. Byxbee
• E. G. Dyer & C i.
SHOE DEALERS—
Thoits' Shoe Store
S. ('. Gibson
..MISCELLANEOUS— ...
Bank of Palo Alto
G. H.Parkinson, Cinhler
Palo Alto Hotel
E. M. Allen, Prop.
Marshall Black
Seu'y P. A. HnlMIng mill Loan
' Werry & Son
Transfer und Shipping
Palm Bakery and Royal Coffee C).
V. E. Purkitm, Mgr.
Palo Alto Home Bakery
, Mm. C. E. liurthuluiuuw, Prop.
G. 11. Allen Oil Co.
Daley Express Co.
J. B. IJuloy, Mfc'i-.
Powell & Dean
Piquing Mill
A. M. Carrel
llui-uugf utid S.ulil lory
Curriugu Hep.»sllory
Itestaurant
Win. J'atnek
C. A. Mosher
Express it Ti-aimfer Co,
C. J, Brown
Ca bluet Make
Sexual health of adolescent girls
No full textSexual health emerges as a key aspect of wellbeing during adolescence. Adolescents’ lives are marked by intense developmental changes, not limited to peak physical growth and cognitive maturation, but major transitions in psychological, social and relationship goals and strivings. For girls, the challenge to achieve sexual health and wellbeing often in spite of external cultural and societal barriers is one that must be supported by evidence-based policy and health resourcing. Here we present the case, using a health and human rights lens, for why adolescent girls’ sexual and reproductive health is a key indicator of women’s health globally. We present the current data on adolescent sexual behaviour, sexuality and gender diversity and health across countries. Vulnerabilities of gender and sexuality diverse young people are explored as are adolescent girls’ challenges in accessing sexual and health services. We discuss why inclusive comprehensive sexuality education is essential to supporting adolescent girls in achieving sexual health and why it should be universal. Effective interventions in schools and the community setting, which have been demonstrated to promote safe sexual behaviour, reduce sexually transmitted infections and unplanned adolescent pregnancies, are summarised
Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide
No full textAbstractBackground: Recruitment of the intracellular tyrosine kinase Syk to activated immune-response receptors is a critical early step in intracellular signaling. In mast cells, Syk specifically associates with doubly phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs) that are found within the IgE receptor. The mechanism by which Syk recognizes these motifs is not fully understood. Both Syk SH2 (Src homology 2) domains are required for high-affinity binding to these motifs, but the C-terminal SH2 domain (Syk-C) can function independently and can bind, in isolation, to the tyrosine-phosphorylated IgE receptor in vitro. In order to improve understanding of the cellular function of Syk, we have determined the solution structure of Syk-C complexed with a phosphotyrosine peptide derived from the γ subunit of the IgE receptor.Results The Syk-C: peptide structure is compared with liganded structures of both the SH2 domain of Src and the C-terminal SH2 domain of ZAP-70 (the 70 kDa zeta-associated protein). The topologies of these domains are similar, although significant differences occur in the loop regions. In the Syk-C structure, the phosphotyrosine and leucine residues of the peptide ligand interact with pockets on the protein, and the intervening residues are extended.Conclusion Syk-C resembles other SH2 domains in its peptide-binding interactions and overall topology, a result that is consistent with its ability to function as an independent SH2 domain in vitro. This result suggests that Syk-C plays a unique role in the intact Syk protein. The determinants of the binding affinity and selectivity of Syk-C may reside in the least-conserved structural elements that comprise the phosphotyrosine- and leucine-binding sites. These structural features can be exploited for the design of Syk-selective SH2 antagonists for the treatment of allergic disorders and asthma
An altered-specificity mutation in a human POU domain demonstrates functional analogy between the POU-specific subdomain and phage lambda repressor.
No full textTime-resolved measurements of sugar-binding-induced conformational changes in the melibiose permease from Escherichia coli
No full textThe melibiose permease (MelB) of E.coli functions as a secondary-active symporter by using the electrochemical H+, Na+, or Li+ gradient to accumulate, e.g., melibiose [review in Pourcher et al. 1990a]. The global and primary objective of this thesis was to apply pre-steady state methods for the investigation of reaction rates of individual steps in the cycle of MelB. Especially the melibiose binding induced transition was investigated by the solid-supported membrane (SSM) technique [Seifert et al. 1993] in combination with a rapid solution exchange system [Pintchovius and Fendler 1999] and with the Stopped-flow technique [Roughton 1934]. To approach this goal, either wild-type or mutated MelB were purified and reconstituted into liposomes as described [Pourcher et al. 1995]. Although the orientation of the proteins is a critical factor for the activity of MelB, it was, so far, unknown. To determine the orientation of the proteins in the liposomes, single Cys mutants R139C and R141C [Abdel-Dayem et al. 2003] were selectively labeled with 3-(N-maleimidylpropionyl)biocytin (MPB) and analyzed by SDS-PAGE and Western Blot. The assay indicated that most of the proteins are inside-out (ISO) oriented permitting to relate the pre-steady state electrical and fluorescence signals to the reverse transport activity of MelB. The melibiose induced electrical signal was investigated in wild-type MelB with the SSM technique. The transporter was activated by a substrate concentration jump, and transient currents were measured. When the transporter was preincubated with Na+ at saturating concentrations, a charge translocation in the protein upon melibiose binding could still be observed. This result demonstrates that binding of the uncharged substrate melibiose triggers a charge displacement in the protein. Further analysis showed that the charge displacement is neither related to extra Na+ binding to the transporter, nor to the displacement of already bound Na+ within MelB. Electrogenic melibiose binding is explained by a conformational change with concomitant displacement of charged amino acid side chains and/or a reorientation of helix dipoles. A kinetic model is suggested, in which Na+ and melibiose binding are distinct electrogenic processes associated with approximately the same charge displacement. Melibiose binding is fast in the presence of Na+ (k > 50 s-1). Furthermore, two previously identified transport deficient mutants of loop 4-5, R141C and E142C [Abdel-Dayem et al. 2002, Séry 2002], were purified and extensively studied with the SSM. Whereas the electrical signals from control cysteine-less mutant showed a bi-exponential time course of decay, those from R141C or E142C consisted of only a single fast exponential component, and the slow decaying component associated with substrate translocation was missing. The electrical signals evoked by a melibiose concentration jump in the presence of Na+ were much smaller than the corresponding signals in C-less MelB. Furthermore, R141C lost the stimulating effect of melibiose on Na+ binding. Steady-state Trp fluorescence spectroscopy revealed impaired conformational changes after melibiose binding in the mutants and fluorescence resonance energy transfer (FRET) measurements indicated that the mutants still show cooperative modification of their sugar binding sites by Na+. These data suggest that loop 4-5 contributes to the coordinated interactions between the ion- and sugar binding site and participates in conformational changes after melibiose binding that are essential for the subsequent obligatory coupled translocation of substrates. By using the Stopped-flow technique, three different approaches were followed. First, the intrinsic Trp fluorescence of MelB, known to increase upon melibiose binding [Mus-Veteau et al. 1995], revealed a signal with a T 1 of ~15 ms in C-less. This time constant is of the same order of magnitude as that determined with the SSM method suggesting that Trp fluorescence and electrical signal are related processes. Conformation for this assumption came from the fact that the activation energies Ea for both processes are similar (around 45 KJ/mol). Second, by using the fluorescent sugar analog Dns2-S-Gal, which monitors events close to the sugar binding site [Maehrel et al. 1998], a signal with a T 1 of ~18 ms was recorded upon Na+ addition. Finally, the fluorescent dye MIANS was used to selectively label the single Cys mutant E365C of loop 10-11. Stopped-flow measurements revealed a melibiose-induced fluorescent signal with a T 1 of 45 ms. Since electrical measurements with the MIANS-labeled E365C excluded the possibility that the label is responsible for the slower kinetics, the conformational change detected by the MIANS fluorescence was assigned to a slow transition in the cycle of MelB after melibiose binding. Ea was determined to be 96 KJ/mol corroborating, thus, the hypothesis of a different process. In conclusion, it was possible to correlate the electrical and fluorescence signals to partial reactions of the transport cycle and to determine their rate constants. According to this new model, the melibiose-induced signal detected with the Trp and electrical measurements corresponds to a step preceding the carriers’ reorientation (3 3*, k ~ 65s-1), and the melibiose-induced signal detected with the MIANS fluorescence to the reorientation itself (3* 4, k ~ 20s-1).Um die Aufnahme und Abgabe von organischen Substraten und Ionen in die Zelle zu ermöglichen, besitzt die Plasmamembran eine Reihe von verschiedenen Transportsystemen. Die Melibiose Permease (MelB) in der zytoplasmatischen Membran von Escherichia Coli ist ein solches Transportsystem und gehört zur Familie der Glykosid-Pentosid-Hexuronid-Transporter. MelB besteht aus 473 Aminosäuren und hat ein Molekulargewicht von 53 kDa. Das Protein ist sehr hydrophob (70% apolar) und hat zwölf Transmembrandomänen mit alpha-helikaler Konformation [Botfield et al. 1992, Gwizdek et al. 1997, Hacksel et al. 2002, Pourcher et al. 1990a]. Der Transport verschiedenster Substrate durch biologische Membranen ist an bereits existierende Gradienten anderer Substrate oder Ionen gekoppelt (sekundärer Transport). So nutzt zum Beispiel MelB den durch andere Systeme geschaffenen elektrochemischen Natriumgradienten, um akkumulierend ein Substrat (zum Beispiel alpha-Galaktoside wie Melibiose oder beta-Galaktoside wie Methyl-1-thio-beta-D-galaktopyranosid) in die Zelle zu befördern. MelB kann als kotransportierende Ionen neben Natrium auch Lithium und Protonen verwenden [Bassilana et al. 1985, Lopilato et al. 1978, Pourcher et al. 1995, Tsuchiya et al. 1978, Tsuchiya et al. 1980, Tsuchiya et al. 1983, Tsuchiya & Wilson 1978, Wilson & Wilson 1987]. Die Kosubstrate binden an den Transporter mit einer Stoichiometrie von 1:1. Des weiteren erhöht die Bindung des Kations die Affinität des Transporters für den Zucker, wobei Na+ und Li+ bessere Aktivatoren als H+ sind. MelB katalysiert die gekoppelte Translokation von Na+ (H+ oder Li+) und Zuckern ebenfalls mit einer Stoichiometrie von 1:1. Die Substratbindung an der Außenseite und die Substratdissoziation ins Zytoplasma erfolgen geordnet, d. h. Na+ bindet zuerst gefolgt von Zucker, wohingegen der Zucker zuerst dissoziiert gefolgt von Na+ [Bassilana et al. 1987, Damiano-Forano et al. 1986, 1988, Pourcher et al. 1990a]. Dabei erhöht das Membranepotential den aktiven Transport, indem es die Rate der Na+-Dissoziation in das Zytoplasma erhöht. Wenn Melibiose in der Zelle ist, wird es von der alpha-Galaktosidase in Glukose und Galaktose gespalten, die beide von der Zelle verstoffwechselt werden und der Energieproduktion dienen. MelB ist ein besonders interessantes Protein für die Untersuchung des Transport-mechanismus, da es verschiedene Zucker und Kationen als Substrate nutzt. Außerdem läßt das Protein sich in großen Mengen herstellen, aufreinigen und in Liposomen rekonstituieren [Pourcher et al. 1995]. Die Melibiose Permease besitzt strukturelle und funktionelle Homologie zu anderen Na+-/Substrat-Kotransportern, die bei biologisch und medizinisch relevanten Prozessen wichtige Funktionen einnehmen. Trotz ihrer Bedeutung sind die Kenntnisse zur Struktur und Funktionsweise dieser Transportproteine sehr begrenzt und deren Aufklärung bleibt weiterhin eine große Herausforderung. MelB dient dabei als Modell, die zugrundeliegenden molekularen Mechanismen sekundär aktiver Na+-Kotransporter besser zu verstehen. Damit können generelle Prinzipien zur Funktionsweise formuliert werden, die auch auf eukaryotische Transporter angewandt werden können, die bei pathophysiologischen Prozessen eine Rolle spielen. Bisher wurden hauptsächlich stationäre Messungen durchgeführt, die einen Einblick in den Gesamtreaktionsmechanismus von MelB gegeben haben [Pourcher et al. 1990a]. Vor kurzem wurden elektrogene Vorgänge, die durch die Aktivität von MelB verursacht worden sind, zum ersten Mal untersucht [Ganea et. al. 2001]. Hierzu wurden Proteoliposomen, die den gereinigten MelB-Transporter enthielten, auf eine festkörperunterstützte Membran (SSM) adsorbiert. Diese Technik ist besonders interessant, da mit Hilfe eines schnellen Lösungs-wechsels Konzentrationssprünge von nahezu jedem beliebigen Substrat an der SSM durchgeführt werden können. Bei dieser ersten Charakterisierung wurde festgestellt, daß die Na+-Bindung an MelB eine Ladungsverschiebung innerhalb des Proteins auslöst, die sich in einer schnell abfallenden Komponente eines transienten Stromsignals widerspiegelt. Mehrere Zwischenschritte innerhalb des Reaktionszyklus wurden bisher nicht oder nur ungenügend charakterisiert. Deswegen bestand die grundlegende Zielsetzung dieser Arbeit darin, vorstationäre, oder pre-steady state Methoden, zur Untersuchung einzusetzen. Diese erlauben es, Reaktionsgeschwindigkeitskonstanten von einzelnen Schritten im Reaktions-zyklus von MelB aufzulösen. Um dieses Ziel zu erreichen, wurden der Wildtyp und verschiedene mutierte Transporter solubilisiert, aufgereinigt und anschließend in Liposomen rekonstitutiert, wie es bereits für MelB beschrieben worden ist [Pourcher et al. 1995, Rigaud et al. 1995]. Die Methode der Aufreinigung und Rekonstitution hat den Vorteil, daß man ohne Wechselwirkung mit anderen zellulären Proteinen die Eigenschaften von MelB untersuchen kann. Die Proteoliposomen wurden in dieser Arbeit hauptsächlich mit der SSM und der Stopped-Flow-Technik untersucht. ..
Pathophysiology of Idiopathic Intracranial Hypertension (IIH)
No full textThis power point describes the pathophysiological mechanisms described in idiopathic intracranial hypertension(IIH). The authors have tried to elaborate the theories behind the development of IIH.1.Idiopathic intracranial hypertension (pseudotumor cerebri): Epidemiology and pathogenesis - UpToDate [Internet]. [cited 2025 Nov 2]. Available from: https://www.uptodate.com/contents/idiopathic-intracranial-hypertension-pseudotumor-cerebri-epidemiology-and-pathogenesis?search=Idiopathic%20intracranial%20hypertension%20%3A%20epidemiology%20and%20pathogensis&source=search_result&selectedTitle=1~92&usage_type=default&display_rank=1. 2.BROWN PD, DAVIES SL, SPEAKE T, MILLAR ID. Molecular Mechanisms of Cerebrospinal Fluid Production. Neuroscience. 2004;129(4):957-70. 3.Colman BD, Boonstra F, Nguyen MN, Raviskanthan S, Sumithran P, White O, et al. Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments. J Neurol Neurosurg Psychiatry. 2024 Mar 13;95(4):375-83. 4.Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS. 2014 May 1;11:10. 5.Ball AK, Sinclair AJ, Curnow SJ, Tomlinson JW, Burdon MA, Walker EA, et al. Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf). 2009 Jun;70(6):863-9. 6.Edwards LJ, Sharrack B, Ismail A, Tench CR, Gran B, Dhungana S, et al. Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol. 2013;2(3):234-44. 7.Altıokka-Uzun G, Tüzün E, Ekizoğlu E, Ulusoy C, Yentür S, Kürtüncü M, et al. Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension. Cephalalgia Int J Headache. 2015 Nov;35(13):1153-61. 8.El-Tamawy MS, Zaki MA, Rashed LA, Esmail EH, Mohamed SS, Osama W. Oligoclonal bands and levels of interleukin 4, interleukin 10, and tumor necrosis factor alpha in idiopathic intracranial hypertension Egyptian patients. Egypt J Neurol Psychiatry Neurosurg. 2019 Dec 19;55(1):88. 9.Westgate CSJ, Botfield HF, Alimajstorovic Z, Yiangou A, Walsh M, Smith G, et al. Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight [Internet]. 2021 May 24 [cited 2025 Nov 23];6(10). Available from: https://insight.jci.org/articles/view/145346. 10.Grech O, Seneviratne SY, Alimajstorovic Z, Yiangou A, Mitchell JL, Smith TB, et al. Nuclear Magnetic Resonance Spectroscopy Metabolomics in Idiopathic Intracranial Hypertension to Identify Markers of Disease and Headache. Neurology. 2022 Oct 18;99(16):e1702-14. 11.O\u27Reilly MW, Westgate CSJ, Hornby C, Botfield H, Taylor AE, Markey K, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight [Internet]. 2019 Mar 21 [cited 2025 Nov 25];4(6). Available from: https://insight.jci.org/articles/view/125348. 12.Fraser JA, Bruce BB, Rucker J, Fraser LA, Atkins EJ, Newman NJ, et al. Risk factors for idiopathic intracranial hypertension in men: a case-control study. J Neurol Sci. 2010 Mar 15;290(1-2):86-9. 13.Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. The BMJ. 2010 Jul 7;341:c2701. 14.Westgate CSJ, Markey K, Mitchell JL, Yiangou A, Singhal R, Stewart P, et al. Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension. Eur J Endocrinol. 2022 May 18;187(2):323-33. 15.Cagnazzo F, Villain M, van Dokkum LE, Radu RA, Morganti R, Gascou G, et al. Concordance between venous sinus pressure and intracranial pressure in patients investigated for idiopathic intracranial hypertension. J Headache Pain. 2024 Sep 17;25(1):153. 16.Cardona-Collazos S, Arias A, Torres-Figueroa S, Meneses CA, Varon CA. Case report: Central venous stenosis-induced intracranial hypertension. Neurocir Engl Ed. 2025 Jul 1;36(4):500652
A Systematic Review and Meta-Analysis of the Role of Peripheral Inflammation in Delirium
No full textINTRODUCTION: The pathophysiology of delirium is poorly understood, but the importance of inflammation is widely accepted. The objective was to investigate whether changes in the peripheral immune system have been associated with the development of delirium in hospitalized adults.METHODS: Embase and MEDLINE databases were searched. Risk of bias was assessed using the Newcastle-Ottawa Scale. Eligible studies were split into three groups: Peripheral immune response was measured (1) preceding delirium, (2) during delirium, and (3) in both incident and prevalent delirium. Quantitative data was extracted and included in the meta-analysis; otherwise, studies were included in the qualitative analysis. (Prospero 102931) RESULTS: 149 records were included in the qualitative synthesis and 92 in the meta-analysis. Measured preceding delirium, there was the strongest evidence for higher neutrophil-to-lymphocyte ratio (NLR) (mean difference (MD) 1.00, 95% Confidence Interval (CI) 0.53, 1.48, p < 0.00001) in those that developed delirium compared to those that did not. During delirium there was strongest evidence for higher interleukin-6 (IL-6) (MD 21.29, 95% CI 11.78, 30.80, p < 0.00001), cortisol (MD 159.6, 95% CI 120.52, 198.68, p < 0.00001), and leukocyte count (MD 0.79, 95% CI 0.51-1.07, p < 0.000001) in delirium compared to no delirium.DISCUSSION: These results support a role for peripheral immune response and inflammation in delirium. However, the heterogeneity of the condition was reflected in the meta-analysis, and we should be cautious extrapolating these results to specific populations. Many studies measured the same soluble markers of inflammation, and a new era of delirium research is needed that transcends this to better understand the condition and develop future treatments.</p
- …
